Leap Therapeutics
LPTX
LPTX
78 hedge funds and large institutions have $139M invested in Leap Therapeutics in 2021 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 19 increasing their positions, 8 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.06% more ownership
Funds ownership: 4.8% → 4.86% (+0.06%)
17% less capital invested
Capital invested by funds: $168M → $139M (-$28.9M)
Holders
78
Holding in Top 10
1
Calls
$1.84M
Puts
$492K
Top Buyers
| 1 | +$6.46M | |
| 2 | +$3.94M | |
| 3 | +$3.67M | |
| 4 |
BlackRock
New York
|
+$3.2M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$2.98M |
Top Sellers
| 1 | -$16M | |
| 2 | -$7.26M | |
| 3 | -$3.11M | |
| 4 |
Renaissance Technologies
New York
|
-$2.96M |
| 5 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$2.31M |